<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="47837">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02483442</url>
  </required_header>
  <id_info>
    <org_study_id>OCOG-2014-PEGeD</org_study_id>
    <nct_id>NCT02483442</nct_id>
  </id_info>
  <brief_title>D-dimer Testing Tailored to Clinical Pretest Probability in Suspected Pulmonary Embolism</brief_title>
  <acronym>PEGeD</acronym>
  <official_title>D-dimer Testing,Tailored to Clinical Pretest Probability to Reduce the Use of CT Pulmonary Angiography in Suspected Pulmonary Embolism: A Management Study (The Pulmonary Embolism Graduated D-dimer [PEGeD] Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multicentre, cohort study assessing a diagnostic management strategy for
      suspected Pulmonary Embolism with independent central adjudication of outcomes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multi-centre, cohort study that will assess a new diagnostic
      management strategy for suspected Pulmonary Embolism (inpatients and outpatients). The new
      diagnostic strategy is designed to reduce the use of imaging tests for Pulmonary Embolism,
      particularly Computed Tomography Pulmonary Angiogram, by excluding Pulmonary Embolism with
      combinations of Clinical Pretest Probability and D-dimer results in a higher proportion of
      patients. The safety of this management strategy will be established by demonstrating a very
      low rate of proximal Deep Vein Thrombosis or Pulmonary Embolism during 90 days of follow-up
      in patients who had anticoagulant therapy withheld in response to negative diagnostic
      testing. Diagnostic test utilization will be assessed. All clinical outcomes will be
      adjudicated by a central independent adjudication committee that will be blind to initial
      D-dimer measurements and patient management.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with confirmed symptomatic proximal Deep Vein Thrombosis or Pulmonary Embolism</measure>
    <time_frame>90 Days (+ or - 7days)</time_frame>
    <description>Proximal Deep Vein Thrombosis includes thrombosis confined to the calf vein trifurcation but not isolated more distal Deep Vein Thrombosis. Pulmonary Embolism does not include isolated sub-segmental abnormalities on Computed Tomography Pulmonary Angiography.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with bleeding</measure>
    <time_frame>90 days (+ or - 7days)</time_frame>
    <description>Major and minor bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patient Deaths</measure>
    <time_frame>90 days (+ or - 7days)</time_frame>
    <description>All deaths and cause specific deaths</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with Venous Thromboembolism</measure>
    <time_frame>90 days (+ or - 7days)</time_frame>
    <description>Venous Thromboembolism, including events that do not satisfy the primary outcome (e.g. isolated distal Deep Vein Thrombosis or subsegmental Pulmonary Embolism) but that are confirmed by the adjudication committee.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>No CT Pulmonary Angiography</arm_group_label>
    <description>Low Clinical Pretest Probability with D-dimer &lt; 1000 ug/L and Moderate Clinical Pretest Probability with D-dimer &lt; 500ug/L</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CT Pulmonary Angiography Required</arm_group_label>
    <description>Low Clinical Pretest Probability with D-dimer &gt; or = 1000ug/L and Moderate Clinical Pretest Probability with D-dimer &gt; or = 500 ug/L and High Clinical Pretest Probability</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Male or female patients (either outpatients or inpatients) with clinically suspected
        Pulmonary Embolism.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients (either outpatients or inpatients) with clinically suspected Pulmonary
             Embolism.

        Exclusion Criteria:

          1. Age less than 18 years.

          2. Treated with full-dose anticoagulation for â‰¥ 24 hours before D-dimer was measured.

          3. Major surgery (general or spinal anesthesia) in the past 21 days.

          4. Result of the D-dimer assay that will be used to manage the patient in the study is
             known before Clinical Pretest Probability was done.

          5. Computed Tomography Pulmonary Angiogram or Ventilation Perfusion Scan was performed:

               1. before Clinical Pretest Probability was documented, or

               2. in a patient with Low Clinical Pretest Probability and a D-dimer level &lt;1,000
                  ug/L (or equivalent), or

               3. in a patient with Moderate Clinical Pretest Probability and a D-dimer level &lt;500
                  ug/L (or equivalent).

          6. Computed Tomography of the chest with contrast will be performed for another reason
             (e.g. to assess for malignant disease or aortic dissection), and would be performed
             even if Pulmonary Embolism is excluded by Clinical Pretest Probability and D-dimer
             testing.

          7. Ongoing need for anticoagulant therapy.

          8. Life expectancy less than 3 months.

          9. Geographic inaccessibility which precludes follow-up.

         10. Known pregnancy.

         11. Inability to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clive Kearon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lisa Rudd-Scott, RN BScN MN</last_name>
    <phone>905-527-2299</phone>
    <phone_ext>43793</phone_ext>
    <email>ruddl@mcmaster.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lucy Spadafora</last_name>
    <phone>905-527-2299</phone>
    <phone_ext>42655</phone_ext>
    <email>spadafl@mcmaster.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G2V2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Bellot</last_name>
      <phone>780-407-7692</phone>
      <email>patricia.bellot@ahs.ca</email>
    </contact>
    <contact_backup>
      <last_name>Rebecca Cairns</last_name>
      <email>rebecca.cairns@ahs.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Cynthia Wu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HHS- Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naomi Bedek</last_name>
      <phone>905-527-4322</phone>
      <phone_ext>43571</phone_ext>
      <email>bedekn@hhsc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Michelle Zondag, RN</last_name>
      <phone>905-527-4322</phone>
      <phone_ext>44807</phone_ext>
      <email>zondag@hhsc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Sam Schulman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Joseph's Healthcare Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alla Glushchenko</last_name>
      <phone>905-522-1155</phone>
      <phone_ext>37394</phone_ext>
      <email>glushcha@mcmaster.ca</email>
    </contact>
    <investigator>
      <last_name>Fred Spencer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HHS - McMaster University Medical Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8S 4K1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Dodds</last_name>
      <phone>905-521-2100</phone>
      <phone_ext>76984</phone_ext>
      <email>doddss@mcmaster.ca</email>
    </contact>
    <investigator>
      <last_name>Shannon Bates, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Juravinski Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pam Stevens, RN</last_name>
      <phone>905-521-2100</phone>
      <phone_ext>43784</phone_ext>
      <email>stevensp@mcmaster.ca</email>
    </contact>
    <investigator>
      <last_name>Clive Kearon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>London Health Sciences</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luljeta Pallaveshi</last_name>
      <phone>519-685-8500</phone>
      <phone_ext>55148</phone_ext>
      <email>luli.pallaveshi@sjhc.london.on.ca</email>
    </contact>
    <investigator>
      <last_name>Alejandro Lazo-Langner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ottawa Hospital - General Campus</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holly Carr</last_name>
      <phone>613-737-8899</phone>
      <phone_ext>73301</phone_ext>
      <email>hcarr@ohri.ca</email>
    </contact>
    <contact_backup>
      <last_name>Anne Marie Clement, RN</last_name>
      <phone>613-737-8899</phone>
      <phone_ext>73389</phone_ext>
      <email>amclement@ohri.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Gregoire Le Gal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jewish General Hospital</name>
      <address>
        <city>Montreal</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Tselios</last_name>
      <phone>514-3408222</phone>
      <phone_ext>3852</phone_ext>
      <email>christos.tselios@mail.mcgill.ca</email>
    </contact>
    <investigator>
      <last_name>Marc Afilalo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 24, 2017</lastchanged_date>
  <firstreceived_date>June 18, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fibrin fragment D</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
